Moors & Cabot, Inc. - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 2 filers reported holding THERAPEUTICSMD INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Moors & Cabot, Inc. ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q1 2022$12,000
+9.1%
30,5000.0%0.00%0.0%
Q4 2021$11,000
-54.2%
30,500
-6.2%
0.00%
-50.0%
Q3 2021$24,000
-44.2%
32,500
-10.8%
0.00%
-33.3%
Q2 2021$43,000
-8.5%
36,450
+3.3%
0.00%
-25.0%
Q1 2021$47,000
+14.6%
35,300
+2.3%
0.00%
+33.3%
Q4 2020$41,000
-51.2%
34,500
-35.3%
0.00%
-62.5%
Q3 2020$84,000
+25.4%
53,3000.0%0.01%
+14.3%
Q2 2020$67,000
+21.8%
53,300
+1.5%
0.01%
-12.5%
Q1 2020$55,000
-57.0%
52,500
-1.5%
0.01%
-38.5%
Q4 2019$128,000
-15.8%
53,300
+27.8%
0.01%
-23.5%
Q3 2019$152,000
+508.0%
41,700
+317.0%
0.02%
+466.7%
Q2 2019$25,00010,0000.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q2 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,460,225$24,914,0004.95%
Newtyn Management, LLC 1,800,000$12,960,0001.95%
1492 Capital Management LLC 222,485$1,602,0001.25%
SANDERS MORRIS HARRIS LLC 967,200$6,964,0001.18%
MORGENS WATERFALL VINTIADIS & CO INC 180,000$1,296,0001.15%
SPHERA FUNDS MANAGEMENT LTD. 580,000$4,176,0000.82%
Rock Springs Capital Management LP 1,600,000$11,520,0000.66%
STONERIDGE INVESTMENT PARTNERS LLC 467,425$3,365,0000.45%
Capital Impact Advisors, LLC 157,411$1,133,0000.45%
GILDER GAGNON HOWE & CO LLC 3,059,690$22,030,0000.37%
View complete list of THERAPEUTICSMD INC shareholders